氟替美维吸入粉雾剂(Trelegy Ellipta)如何用药

Flutimavir inhalation powder spray (TrelegyEllipta) is taken once a day, one inhalation each time. Rinse your mouth after inhalation and use the medicine correctly under the guidance of a doctor.

How to use Flutimavir Inhalation Powder Aerosol (Trelegy Ellipta)

1. Frequency and dosage

It should be used once a day, one inhalation each time, by oral inhalation. Not for use more than once daily and not for relief of acute bronchospasm.

2. Usage steps

(1). Preparation stage: Open the nozzle cover and hear a "click" sound to indicate that the medicine is ready.

(2) Exhale: Move the nozzle away from the mouth and exhale completely.

(3) Inhalation: Put the nozzle into your mouth, close your lips tightly, and take a deep breath.

(4) Breath-hold: Remove the inhaler and hold your breath for about 3-4 seconds.

(5) Exhale and close: Exhale slowly and close the nozzle cover.

(6) Mouthwash: Rinse your mouth with water immediately after use and do not swallow to reduce the risk of oral candida infection.

3. Precautions

(1) Do not disassemble the inhaler.

(2) If you miss one inhalation, you should take another inhalation as soon as you remember, and take the medicine at the original time the next day. Do not inhale a double dose at one time.

(3). The inhaler should be used within 6 weeks after opening, or discarded when the counter shows "0".

The pictures are from public channels (such as the official website of the FDA, the official website of the original drug manufacturer, etc.) and are for reference only.

Dosage of flutimavir inhalation powder (Trelegy Ellipta)

1. Dosage for patients with chronic obstructive pulmonary disease

The recommended dose is once a day, one inhalation each time (specification: 100/62.5/25mcg).

2. Dosage for asthma patients

The starting dose can be 100/62.5/25mcg or 200/62.5/25mcg, once a day.

3. Treatment of acute attacks

Flutimavir inhalation powder cannot be used for acute attacks. Patients should prepare short-acting β2-receptor agonists (such as salbutamol) as emergency drugs. If emergency medication is used more frequently or becomes less effective, seek medical attention immediately.

Flutimavir Inhalation Powder Aerosol (Trelegy Ellipta) Medication for Special Populations

1. Elderly Patients

Elderly patients generally do not need to adjust the dose, but it should be noted that individual sensitivity to the drug may be increased, and they should be closely observed for adverse reactions.

2. Patients with hepatic insufficiency

Patients with moderate to severe hepatic insufficiency should use this product with caution. Systemic exposure of fluticasone may be increased and patients should be monitored for corticosteroid-related adverse effects.

3. Children and Adolescents

Flutimavir inhalation powder is not approved for use in people under the age of 18, and its safety and effectiveness have not been established.